The crystal structure of hexaqua(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-1κ2O,O′;2κO′)(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O,O′)digadolinium(III) octahydrate, C60H76Gd2N18O32

The crystal structure of hexaqua(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-1κ2O,O′;2κO′)(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O,O′)digadolinium(III) octahydrate, C60H76Gd2N18O32

C60H76N18O32Gd2, monoclinic, P21/c (no. 14), a = 10.560(5) Å, b = 31.243(5) Å, c = 12.383(4) Å, β = 116.51(3)°, V = 3656(2) Å3, Z = 2, Rgt(F) = 0.0470, wRref(F2) = 0.1013, T = 293(2) K.

Bibliographic Details
Main Authors: Chen Qifan, Huang Fang, Quan Wenjing, Lu Yanhua, Zhang Fang, Liu Fei
Format: Article
Language:English
Published: De Gruyter 2016-06-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Subjects:
1456749
Online Access:https://doi.org/10.1515/ncrs-2015-0136

Internet

https://doi.org/10.1515/ncrs-2015-0136

Similar Items